Literature DB >> 11222728

Establishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.

K M Haan1, A Aiyar, R Longnecker.   

Abstract

Epstein-Barr virus (EBV) is a strict human pathogen for which no small animal models exist. Plasmids that contain the EBV plasmid origin of replication, oriP, and express EBV nuclear antigen 1 (EBNA1) are stably maintained extrachromosomally in human cells, whereas these plasmids replicate poorly in rodent cells. However, the ability of oriP and EBNA1 to maintain the entire EBV episome in proliferating rodent cells has not been determined. Expression of the two human B-cell receptors for EBV on the surfaces of murine B cells allows efficient viral entry that leads to the establishment of latent EBV infection and long-term persistence of the viral genome. Latent gene expression in these cells resembles the latency II profile in that EBNA1 and LMP1 can be detected whereas EBNA2 and the EBNA3s are not expressed.

Entities:  

Mesh:

Year:  2001        PMID: 11222728      PMCID: PMC115929          DOI: 10.1128/JVI.75.6.3016-3020.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.

Authors:  K M Haan; W W Kwok; R Longnecker; P Speck
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  Epstein-Barr virus infection.

Authors:  J I Cohen
Journal:  N Engl J Med       Date:  2000-08-17       Impact factor: 91.245

3.  Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Authors:  A Janz; M Oezel; C Kurzeder; J Mautner; D Pich; M Kost; W Hammerschmidt; H J Delecluse
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Presence of EBV antibodies in sera from wild chimpanzees.

Authors:  J A Levy; S B Levy; Y Hirshaut; G Kafuko; A Prince
Journal:  Nature       Date:  1971-10-22       Impact factor: 49.962

5.  Herpes-type virus in cultured leukocytes from chimpanzees.

Authors:  J C Landon; L B Ellis; V H Zeve; D P Fabrizio
Journal:  J Natl Cancer Inst       Date:  1968-01       Impact factor: 13.506

6.  Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infection.

Authors:  K M Haan; R Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.

Authors:  P Norio; C L Schildkraut; J L Yates
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.

Authors:  H Molina; C Brenner; S Jacobi; J Gorka; J C Carel; T Kinoshita; V M Holers
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

9.  Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus.

Authors:  P Gerber; R F Pritchett; E D Kieff
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

10.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

Authors:  G Klein; T Lindahl; M Jondal; W Leibold; J Menézes; K Nilsson; C Sundström
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

View more
  6 in total

1.  Cell Intrinsic Factors Modulate the Effects of IFNγ on the Development of Chlamydia trachomatis.

Authors:  Shardulendra Sherchand; Joyce A Ibana; Alison J Quayle; Ashok Aiyar
Journal:  J Bacteriol Parasitol       Date:  2016-07-25

Review 2.  Blood-brain barrier transport of non-viral gene and RNAi therapeutics.

Authors:  Ruben J Boado
Journal:  Pharm Res       Date:  2007-06-08       Impact factor: 4.200

Review 3.  Epstein-Barr Virus: Diseases Linked to Infection and Transformation.

Authors:  Hem C Jha; Yonggang Pei; Erle S Robertson
Journal:  Front Microbiol       Date:  2016-10-25       Impact factor: 5.640

Review 4.  Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.

Authors:  Shyam Singh; Hem Chandra Jha
Journal:  J Oncol       Date:  2017-03-21       Impact factor: 4.375

5.  Restricted expression of Epstein-Barr virus latent genes in murine B cells derived from embryonic stem cells.

Authors:  Magdalena Zychlinska; Heidrun Herrmann; Ursula Zimber-Strobl; Wolfgang Hammerschmidt
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

6.  Effects of Epstein-Barr Virus Infection on CD19+ B Lymphocytes in Patients with Immunorelated Pancytopenia.

Authors:  Yang Zhao; Yihao Wang; Hui Liu; Kai Ding; Chunyan Liu; Hong Yu; Zonghong Shao; Rong Fu
Journal:  J Immunol Res       Date:  2020-02-17       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.